STAAR Surgical Total Liabilities 2010-2024 | STAA
STAAR Surgical total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
STAAR Surgical Annual Total Liabilities (Millions of US $) |
2023 |
$103 |
2022 |
$83 |
2021 |
$87 |
2020 |
$60 |
2019 |
$48 |
2018 |
$35 |
2017 |
$25 |
2016 |
$28 |
2015 |
$24 |
2014 |
$22 |
2013 |
$23 |
2012 |
$23 |
2011 |
$20 |
2010 |
$18 |
2009 |
$38 |
STAAR Surgical Quarterly Total Liabilities (Millions of US $) |
2024-09-30 |
$109 |
2024-06-30 |
$104 |
2024-03-31 |
$100 |
2023-12-31 |
$103 |
2023-09-30 |
$93 |
2023-06-30 |
$87 |
2023-03-31 |
$80 |
2022-12-31 |
$83 |
2022-09-30 |
$75 |
2022-06-30 |
$77 |
2022-03-31 |
$75 |
2021-12-31 |
$87 |
2021-09-30 |
$75 |
2021-06-30 |
$60 |
2021-03-31 |
$52 |
2020-12-31 |
$60 |
2020-09-30 |
$48 |
2020-06-30 |
$43 |
2020-03-31 |
$42 |
2019-12-31 |
$48 |
2019-09-30 |
$43 |
2019-06-30 |
$42 |
2019-03-31 |
$40 |
2018-12-31 |
$35 |
2018-09-30 |
$34 |
2018-06-30 |
$32 |
2018-03-31 |
$32 |
2017-12-31 |
$25 |
2017-09-30 |
$32 |
2017-06-30 |
$25 |
2017-03-31 |
$28 |
2016-12-31 |
$28 |
2016-09-30 |
$29 |
2016-06-30 |
$27 |
2016-03-31 |
$24 |
2015-12-31 |
$24 |
2015-09-30 |
$22 |
2015-06-30 |
$21 |
2015-03-31 |
$20 |
2014-12-31 |
$22 |
2014-09-30 |
$22 |
2014-06-30 |
$23 |
2014-03-31 |
$23 |
2013-12-31 |
$23 |
2013-09-30 |
$22 |
2013-06-30 |
$20 |
2013-03-31 |
$20 |
2012-12-31 |
$23 |
2012-09-30 |
$19 |
2012-06-30 |
$18 |
2012-03-31 |
$18 |
2011-12-31 |
$20 |
2011-09-30 |
$18 |
2011-06-30 |
$17 |
2011-03-31 |
$17 |
2010-12-31 |
$18 |
2010-09-30 |
$17 |
2010-06-30 |
$16 |
2010-03-31 |
$32 |
2009-12-31 |
$38 |
2009-09-30 |
$37 |
2009-06-30 |
$36 |
2009-03-31 |
$35 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$1.288B |
$0.322B |
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|